Mark Baker
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Cancer therapeutics and mechanisms 2
- RNA Interference and Gene Delivery 2
-
- HIV/AIDS drug development and treatment 3
- Co-authors
- Didier Merlin (7 shared papers)Hamed Laroui (5 shared papers)Émilie Viennois (7 shared papers)Saravanan Ayyadurai (3 shared papers)Moiz A. Charania (2 shared papers)Bo Xiao (5 shared papers)Yutao Yan (2 shared papers)Fengyuan Chen (1 shared paper)
- Journals
- Open Forum Infectious Diseases (3 papers)Anti-Cancer Drugs (2 papers)Cell Metabolism (1 paper)Scientific Reports (1 paper)Biomaterials (1 paper)
- Partner nations
- United StatesChinaNew Zealand
In The Last Decade
Mark Baker
15 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 99
- Pharmaceutical Science 119
- Biomaterials 121
- Genetics 244
- Molecular Medicine 43
- Gastroenterology 44
Countries citing papers authored by Mark Baker
This map shows the geographic impact of Mark Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Baker more than expected).
Fields of papers citing papers by Mark Baker
This network shows the impact of papers produced by Mark Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Baker. The network helps show where Mark Baker may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 267 | |
| 2 | 2014 | 166 | |
| 3 | 2013 | 145 | |
| 4 | 2015 | 127 | |
| 5 | 2015 | 88 | |
| 6 | 2002 | 50 | |
| 7 | 2014 | 44 | |
| 8 | 2001 | 44 | |
| 9 | 2013 | 29 | |
| 10 | 2014 | 21 | |
| 11 | 2019 | 17 | |
| 12 | 2021 | 13 | |
| 13 | 2019 | 9 | |
| 14 | 2018 | 7 | |
| 15 | 2002 | 1 |
About Mark Baker
Mark Baker is a scholar working on Molecular Biology, Infectious Diseases, Genetics, Oncology and Nutrition and Dietetics, having authored 15 papers that have together received 1.0k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (4 papers), HIV/AIDS drug development and treatment (3 papers), HIV Research and Treatment (2 papers), Cancer therapeutics and mechanisms (2 papers), Infant Nutrition and Health (2 papers), Lung Cancer Research Studies (2 papers), RNA Interference and Gene Delivery (2 papers) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Pharmaceutical Science (119 citations), Biomaterials (121 citations), Genetics (244 citations), Molecular Medicine (43 citations) and Gastroenterology (44 citations). Mark Baker has collaborated with scholars based in United States, China and New Zealand. Frequent co-authors include Didier Merlin, Hamed Laroui, Émilie Viennois, Saravanan Ayyadurai, Moiz A. Charania, Bo Xiao, Yutao Yan, Fengyuan Chen, Shanthi V. Sitaraman and Sarah Ingersoll. Their work appears in journals such as Open Forum Infectious Diseases, Anti-Cancer Drugs, Cell Metabolism, Scientific Reports and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.